Business
Omega Reports Second Quarter 2025 Results and Recent Developments
HUNT VALLEY, Md., July 31, 2025--Omega Healthcare Investors, Inc. (NYSE: OHI) (the "Company" or "Omega") announced today its results for the quarter ended June 30, 2025.
About this update from Omega Healthcare Investors, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":3600,"height":900,"url":"https://media.zenfs.com/en/business-wire.com/0b46ad933ac3d41a138f4080839462cf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/aD1xkiTcf_30ivIIJ1xk4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0b46ad933ac3d41a138f4080839462cf","width":960,"height":240},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/VjfkEbc7..BBBpZ2jpEeJw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/0b46ad933ac3d41a138f4080839462cf","width":1200,"height":300}},"lazy":false},{"type":"text","content":"Completed $527 Million in New Investments in Q2","length":47,"tagName":"p","attribs":{}},{"type":"text","content":"Issued $600 Million of 5.2% Notes due 2030 in Q2","length":48,"tagName":"p","attribs":{}},{"type":"text","content":"Increases Full Year Adjusted FFO Guidance","length":41,"tagName":"p","attribs":{}},{"type":"text","content":"HUNT VALLEY, Md., July 31, 2025--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) (the "Company" or "Omega") announced today its results for the quarter ended June 30, 2025.","length":206,"tagName":"p"},{"type":"text","content":"SECOND QUARTER 2025 AND RECENT HIGHLIGHTS","length":41,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net income for the quarter of $140 million, or $0.46 per common share, compared to $117 million, or $0.45 per common share, for Q2 2024.","length":136,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted Funds From Operations ("Adjusted FFO" or "AFFO") for the quarter of $232 million, or $0.77 per common share, on 303 million weighted-average common shares outstanding, compared to $185 million, or $0.71 per common share, on 262 million weighted-average common shares outstanding, for Q2 2024.","length":321,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Funds Available for Distribution ("FAD") for the quarter of $223 million, or $0.74 per common share, compared to FAD of $177 million, or $0.68 per common share, for Q2 2024.","length":183,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Completed approxima...